Peter Holme Jensen
Founder en Silico Pharma ApS .
Fortuna: 987 102 $ al 31/03/2024
Perfil
Peter Holme Jensen is the founder of ENKAM Pharmaceuticals A (founded in 2000) and Aquaporin A (founded in 2005).
At Aquaporin A, he held the title of Chief Innovation Officer from 2022 to 2024.
Dr. Jensen is also the founder of Silico Pharma ApS.
Currently, he holds the position of Director at InnovationsFonden and Aquaporin Space Alliance ApS.
Dr. Jensen holds a doctorate degree from the University of Copenhagen and a graduate degree from the University of Southern Denmark.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AQUAPORIN A/S
1.92% | 31/12/2022 | 210 659 ( 1.92% ) | 987 102 $ | 31/03/2024 |
Cargos activos de Peter Holme Jensen
| Empresas | Cargo | Inicio |
|---|---|---|
| Silico Pharma ApS | Founder | 14/04/2010 |
Aquaporin Space Alliance ApS
 Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Director/Board Member | - |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Antiguos cargos conocidos de Peter Holme Jensen.
| Empresas | Cargo | Fin |
|---|---|---|
| AQUAPORIN A/S | Chief Executive Officer | 01/01/2022 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Founder | 09/12/2008 |
Formación de Peter Holme Jensen.
| University of Copenhagen | Doctorate Degree |
| University of Southern Denmark | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AQUAPORIN A/S | Producer Manufacturing |
| Empresas privadas | 4 |
|---|---|
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Silico Pharma ApS | |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Finance |
Aquaporin Space Alliance ApS
Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Electronic Technology |
- Bolsa de valores
- Insiders
- Peter Holme Jensen
